IP Library Granted Patent US 12,397,103
Granted Patent B2
US 12,397,103 · App. 18/653,817 · Granted Aug 26, 2025

Infusion line systems

Inventors: Wayne A. Provost (St. George, UT); Jeffrey D. Stewart (Washington, UT)
Assignee: ORION INNOVATIONS INC.
A61M5/14A61M39/10G02B6/0006G06F21/35A61M2205/587A61M2205/6081G02B6/001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,397,103
App. No.
18/653,817
Granted
Aug 26, 2025
Kind
B2
Abstract

An IV-line identification system to enable ready identification of an IV line and its associated fluid source and output from other IV lines with their fluid sources and outputs. The IV-line identification system includes an optical member affixed along a longitudinal length of an elongated member that transmits light when a light source provides a light to the optical member.

Claims (54)

1. A kit for providing visual identification of an infusion line, the kit comprising:

a first light source configured for selective attachment to an infusion line, the first light source being actuatable to generate a light signal upon actuation;

a second light source configured for selective attachment to an infusion line, the second light source being actuatable to generate a light signal upon actuation,

wherein the first and second light sources are communicatively connectable to one another via a wireless connection,

wherein the first light source is configured to, upon actuation,

(i) generate a light signal at the first light source,

(ii) automatically establish the wireless connection with second light source, and

(iii) automatically activate the second light source to cause the second light source to generate a light signal at the second light source, and

wherein the second light source is configured to, upon actuation,

(i) generate a light signal at the second light source,

(ii) automatically establish the wireless connection with the first light source, and

(iii) automatically activate the first light source to cause the first light source to generate a light signal at the first light source.

2. The kit of claim 1 , wherein the first light source, the second light source, or both include a manual switch to enable actuation.

3. The kit of claim 1 , wherein the first light source, the second light source, or both include one or more clips enabling the selective attachment to an infusion line.

4. The kit of claim 1 , wherein the first light source, the second light source, or both include a battery protector configured to prevent actuation until the battery protector has been removed.

5. The kit of claim 1 , wherein the first light source, the second light source, or both are configured to provide light for a duration of about 72 to 120 hours.

6. The kit of claim 1 , further comprising an additional light source, wherein the additional light source is communicatively connectable to the first and second light sources via the wireless connection, and wherein the additional light source is configured to automatically generate a light signal upon actuation of the first light source and/or second light source.

7. The kit of claim 6 , wherein the additional light source is a pump assembly that includes a light.

8. The kit of claim 7 , wherein the pump assembly includes a peristaltic pump.

9. The kit of claim 7 , wherein the pump assembly includes one or more charging ports for receiving the first and/or second light source to charge the first and/or second light source.

10. The kit of claim 1 , wherein the wireless connection is an ultrahigh frequency radio wave connection.

11. An infusion line assembly, comprising:

an infusion line configured for administering fluid to a patient;

a first light source configured for selective attachment to the infusion line, the first light source being actuatable to generate a light signal upon actuation;

a second light source configured for selective attachment to the infusion line, the second light source being actuatable to generate a light signal upon actuation,

wherein the first and second light sources are communicatively connectable to one another via a wireless connection,

wherein the first light source is configured to, upon actuation,

(i) generate a light signal at the first light source,

(ii) automatically establish the wireless connection with second light source, and

(iii) automatically activate the second light source to cause the second light source to generate a light signal at the second light source, and

wherein the second light source is configured to, upon actuation,

(i) generate a light signal at the second light source,

(ii) automatically establish the wireless connection with the first light source, and

(iii) automatically activate the first light source to cause the first light source to generate a light signal at the first light source.

12. The assembly of claim 11 , wherein the first light source, the second light source, or both include a manual switch to enable actuation.

13. The assembly of claim 11 , wherein the first light source, the second light source, or both include one or more clips enabling the selective attachment to an infusion line.

14. The assembly of claim 11 , further comprising an additional light source, wherein the additional light source is communicatively connectable to the first and second light sources via the wireless connection, and wherein the additional light source is configured to automatically generate a light signal upon actuation of the first light source and/or second light source.

15. The assembly of claim 14 , wherein the additional light source is a pump assembly that includes a light.

16. A method of modifying an infusion line to enhance identifiability of the infusion line, the method comprising:

attaching a first light source to the infusion line, the first light source being actuatable to generate a light signal upon actuation;

attaching a second light source to the infusion line, the second light source being actuatable to generate a light signal upon actuation,

wherein the first and second light sources are communicatively connectable to one another via a wireless connection,

wherein the first light source is configured to, upon actuation,

(i) generate a light signal at the first light source,

(ii) automatically establish the wireless connection with second light source, and

(iii) automatically activate the second light source to cause the second light source to generate a light signal at the second light source, and

wherein the second light source is configured to, upon actuation,

(i) generate a light signal at the second light source,

(ii) automatically establish the wireless connection with the first light source, and

(iii) automatically activate the first light source to cause the first light source to generate a light signal at the first light source; and

actuating one of the first or second light sources to cause generation of light signals at both the first and second light sources.

17. The method of claim 16 , wherein the first light source, the second light source, or both include a manual switch to enable actuation.

18. The method of claim 16 , wherein actuating one of the first or second light sources to cause generation of light signals at both the first and second light sources also causes generation of a light signal at an additional light source that is communicatively connectable to the first and second light sources via the wireless connection.

19. The method of claim 18 , wherein the additional light source is a pump assembly that includes a light.

Assignments (7)
SECURITY INTEREST Recorded Apr 16, 2026
From: ORION INNOVATIONS, INC.; OXYSWITCH, LLC; OLSON, ROBERT; OLSON, DESHKA; PROVOST, WAYNE; MJ STEWART INVESTMENTS; MEDLITE ID, INC.
To: LIFE TECH, LLC
Reel/Frame 074391/0779 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2024
From: PROVOST, WAYNE A.; STEWART, JEFFREY D.
To: MJ STEWART INVESTMENTS, LLC
Reel/Frame 069245/0652 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2024
From: MJ STEWART INVESTMENTS, LLC
To: MEDLITE ID INC.
Reel/Frame 069245/0969 →
CHANGE OF NAME Recorded Nov 13, 2024
From: MEDLITE ID INC.
To: ORION INNOVATIONS INC.
Reel/Frame 069354/0125 →
CHANGE OF NAME Recorded Nov 6, 2024
From: MEDLITE ID INC.
To: ORION INNOVATIONS INC.
Reel/Frame 069313/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2024
From: MJ STEWART INVESTMENTS, LLC
To: MEDLITE ID INC.
Reel/Frame 069154/0395 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2024
From: PROVOST, WAYNE A.; STEWART, JEFFREY D.
To: MJ STEWART INVESTMENTS, LLC
Reel/Frame 069154/0328 →
Continuity (10)
Continuation 18120935 · Mar 13, 2023
Continuation 17564587 · Dec 29, 2021
Continuation 17191674 · Mar 3, 2021
Continuation 16909111 · Jun 23, 2020
Continuation 16548067 · Aug 22, 2019
Continuation 16053495 · Aug 2, 2018
Continuation 15902682 · Feb 22, 2018
Continuation In Part 15618799 · Jun 9, 2017
Provisional Application 62354617 · Jun 24, 2016
Related Publication 20240350721A1 · Oct 24, 2024
References Cited (47)
US 5316473A · Hare · 1994 [cited by applicant]
US 6984052B1 · Del Castillo · 2006 [cited by examiner]
US D518261S · Varga · 2006 [cited by applicant]
US 9308051B2 · Adams et al. · 2016 [cited by applicant]
US 10639416B2 · Utz · 2020 [cited by applicant]
US 10722641B2 · Provost et al. · 2020 [cited by applicant]
US 11241528B2 · Provost et al. · 2022 [cited by applicant]
US 20040160770A1 · Rodriguez · 2004 [cited by examiner]
US 20070088286A1 · Brier · 2007 [cited by applicant]
US 20070100222A1 · Mastrototaro et al. · 2007 [cited by applicant]
US 20070106263A1 · Ward · 2007 [cited by applicant]
US 20080033519A1 · Burwell · 2008 [cited by examiner]
US 20080177145A1 · Furnish · 2008 [cited by applicant]
US 20110197397A1 · Pang · 2011 [cited by applicant]
US 20130208497A1 · Provost · 2013 [cited by examiner]
US 20140061421A1 · Lane · 2014 [cited by applicant]
US 20140327759A1 · Tao · 2014 [cited by applicant]
US 20170216522A1 · Slepicka et al. · 2017 [cited by applicant]
US 20170258983A1 · Utz · 2017 [cited by applicant]
US 20170368255A1 · Provost et al. · 2017 [cited by applicant]
US 20180140770A1 · Hetchler et al. · 2018 [cited by applicant]
US 20180177938A1 · Provost et al. · 2018 [cited by applicant]
US 20180344923A1 · Provost et al. · 2018 [cited by applicant]
US 20190374703A1 · Provost et al. · 2019 [cited by applicant]
US 20200316288A1 · Provost et al. · 2020 [cited by applicant]
US 20210187187A1 · Provost et al. · 2021 [cited by applicant]
US 20220118174A1 · Provost et al. · 2022 [cited by applicant]
US 20220143313A1 · Lee et al. · 2022 [cited by applicant]
US 20230293807A1 · Provost et al. · 2023 [cited by applicant]
US 20240123136A1 · Provost · 2024 [cited by applicant]
US 20240123209A1 · Provost et al. · 2024 [cited by applicant]
CN 104548260A · 2015 [cited by applicant]
EP 2371411A1 · 2011 [cited by applicant]
WO 2010010358A1 · 2010 [cited by applicant]
WO 2011127043A1 · 2011 [cited by applicant]
WO 2013192235A1 · 2013 [cited by applicant]
WO 2022212560A1 · 2022 [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2023/077229, mailed on Feb. 22, 2024, 12 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2023/077231, mailed on Feb. 23, 2024, 27 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 15/618,799, mailed on Jul. 14, 2020, 17 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/US02019/018826 dated May 22, 2019. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 16/909,111, mailed on Jul. 20, 2020, 9 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 17/564,587, mailed on Jul. 18, 2022, 9 pages. [cited by applicant]
Notice of Allowance received for U.S. Appl. No. 16/909,111, mailed on Dec. 3, 2020, 10 pages. [cited by applicant]
Office Action received for U.S. Appl. No. 15/618,799, mailed on Oct. 28, 2019. [cited by applicant]
Office Action received for U.S. Appl. No. 16/053,495, mailed on Sep. 24, 2018. [cited by applicant]
Office Action received for U.S. Appl. No. 16/548,067, mailed on Sep. 12, 2019. [cited by applicant]